Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
5.53
-0.07 (-1.25%)
Jul 30, 2025, 4:00 PM - Market closed

Treace Medical Concepts Stock Forecast

Stock Price Forecast

The 5 analysts that cover Treace Medical Concepts stock have a consensus rating of "Hold" and an average price target of $9.42, which forecasts a 70.34% increase in the stock price over the next year. The lowest target is $8 and the highest is $14.5.

Price Target: $9.42 (+70.34%)
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Price$8.00$9.42$8.00$14.5
Change+44.67%+70.34%+44.67%+162.21%
* Price targets were last updated on May 9, 2025.

Analyst Ratings

The average analyst rating for Treace Medical Concepts stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy111111
Buy000000
Hold777554
Sell000000
Strong Sell000000
Total888665

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
UBS
UBS
Hold
Maintains
$10$8.6
HoldMaintains$10$8.6+55.52%May 9, 2025
Truist Securities
Truist Securities
Hold
Maintains
$9.5$8
HoldMaintains$9.5$8+44.67%Apr 11, 2025
Truist Securities
Truist Securities
Hold
Maintains
$10$9.5
HoldMaintains$10$9.5+71.79%Mar 13, 2025
Truist Securities
Truist Securities
Hold
Maintains
$8.4$10
HoldMaintains$8.4$10+80.83%Mar 3, 2025
Lake Street
Lake Street
Strong Buy
Initiates
$15
Strong BuyInitiates$15+162.21%Dec 31, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
231.57M
from 209.36M
Increased by 10.61%
Revenue Next Year
255.68M
from 231.57M
Increased by 10.41%
EPS This Year
-0.81
from -0.90
EPS Next Year
-0.71
from -0.81
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
57.37M94.42M141.84M187.12M209.36M231.57M255.68M272.48M
Revenue Growth
45.54%64.59%50.22%31.92%11.89%10.61%10.41%6.57%
EPS
-0.12-0.43-0.77-0.81-0.90-0.81-0.71-0.69
EPS Growth
--------
Forward PE
--------
No. Analysts
-----887
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027
High238.7M269.9M285.8M
Avg231.6M255.7M272.5M
Low222.2M241.1M259.7M

Revenue Growth

Revenue Growth202520262027
High
14.0%
16.5%
11.8%
Avg
10.6%
10.4%
6.6%
Low
6.1%
4.1%
1.6%

EPS Forecast

EPS202520262027
High-0.80-0.61-0.63
Avg-0.81-0.71-0.69
Low-0.81-0.78-0.78

EPS Growth

EPS Growth202520262027
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.